Difference between revisions of "Team:Bordeaux/Practices"
Line 107: | Line 107: | ||
<br>In order to limit this fear, the question of transparency is important for scientists. Besides publishing his results, the researcher has to be able to explain his research process and the challenges of the project by stating the explored and the ignored areas. The general audience has to be able to understand his whole scientific approach. The results found, thanks to this approach, contribute to the production of new knowledge and innovation that could be shared to the general public. It is also important for the researcher to analyze his results, looking at the possible negative impacts of his research and estimating the safety and environmental risks and as well the ethical problematic.</p> | <br>In order to limit this fear, the question of transparency is important for scientists. Besides publishing his results, the researcher has to be able to explain his research process and the challenges of the project by stating the explored and the ignored areas. The general audience has to be able to understand his whole scientific approach. The results found, thanks to this approach, contribute to the production of new knowledge and innovation that could be shared to the general public. It is also important for the researcher to analyze his results, looking at the possible negative impacts of his research and estimating the safety and environmental risks and as well the ethical problematic.</p> | ||
− | <p align=" | + | <p align="center"><i>However, the researcher cannot be the only one in charge of the safety and ethics of his research.</i></p> |
<h5 align="center" >The synthetic biology legal framework in Europe</h5> | <h5 align="center" >The synthetic biology legal framework in Europe</h5> | ||
Line 125: | Line 125: | ||
<p align="justify">Specifically for synthetic biology, a European project called SYNBIOSAFE approved by the European Commission has focused on ethics and safety of synthetic biology. In 2012, it published an <a href="http://www.biofaction.com/wp-content/uploads/2012/04/igem-biosafety-2013.pdf" target="_blank">article</a> concerning the bioethical and biosafety attentions in iGEM competitions.</p> | <p align="justify">Specifically for synthetic biology, a European project called SYNBIOSAFE approved by the European Commission has focused on ethics and safety of synthetic biology. In 2012, it published an <a href="http://www.biofaction.com/wp-content/uploads/2012/04/igem-biosafety-2013.pdf" target="_blank">article</a> concerning the bioethical and biosafety attentions in iGEM competitions.</p> | ||
− | <p align=" | + | <p align="center"><i>Thanks to the laws concerning ethical aspects of science (ref) and projects like SYNBIOSAFE that focus on synthetic biology, many ethical questions arose on synthetic biology and we have tried to answer them in the clearest way possible. Therefore, not only law may limit synthetic biology. Aspects concerning Politics, Economy, and Philosophy could influence the bioethics questions.</i></p> |
</div> | </div> | ||
Revision as of 22:49, 5 August 2015